GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Price-to-Owner-Earnings

CrystalGenomics Invites Co (XKRX:083790) Price-to-Owner-Earnings : (As of Jun. 10, 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Price-to-Owner-Earnings?

As of today (2024-06-10), CrystalGenomics Invites Co's share price is ₩2515.00. CrystalGenomics Invites Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for CrystalGenomics Invites Co's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of CrystalGenomics Invites Co was 4343.39. The lowest was 221.92. And the median was 2076.47.


XKRX:083790's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.2
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-10), CrystalGenomics Invites Co's share price is ₩2515.00. CrystalGenomics Invites Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-710.00. Therefore, CrystalGenomics Invites Co's PE Ratio for today is At Loss.

As of today (2024-06-10), CrystalGenomics Invites Co's share price is ₩2515.00. CrystalGenomics Invites Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-210.63. Therefore, CrystalGenomics Invites Co's PE Ratio without NRI for today is At Loss.

During the past 13 years, CrystalGenomics Invites Co's highest PE Ratio without NRI was 1375.12. The lowest was 0.00. And the median was 294.97.


CrystalGenomics Invites Co Price-to-Owner-Earnings Historical Data

The historical data trend for CrystalGenomics Invites Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co Price-to-Owner-Earnings Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CrystalGenomics Invites Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, CrystalGenomics Invites Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's Price-to-Owner-Earnings falls into.



CrystalGenomics Invites Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CrystalGenomics Invites Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2515.00/-3111.52
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CrystalGenomics Invites Co  (XKRX:083790) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CrystalGenomics Invites Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines